Bildkälla: Stockfoto

aXichem Q1’22: Taking Steps in the Right Direction - Redeye

Redeye provides its comments on aXichem’s Q1’22 report. With increasing activity in both segments as well as pending feed additive approvals in both the EU and Brazil, aXichem is preparing for scaling up its commercial activities.

Redeye provides its comments on aXichem’s Q1’22 report. With increasing activity in both segments as well as pending feed additive approvals in both the EU and Brazil, aXichem is preparing for scaling up its commercial activities.
Börsvärldens nyhetsbrev
ANNONSER